This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
There are ton of high-growth stocks out there. Everyone talks about the FANGs all the time. There are also all the hyper-growth Chinese internet stocks, the class of digital retailers which are riding e-commerce tailwinds to super-charged growth rates, all those big-growth cloud companies and a ton more.
BABA SHOP AMZN IRBT ADBE
It wasn't surprising to see the shorts and bears jump on the Supreme Court decision in favor of South Dakota in its battle against Wayfair, in regard to its perceived impact on Shopify (NYSE:SHOP).
TWMJF SHOP WEED CGC
DocuSign (NASDAQ:DOCU), popular e-signature company, has been a hot stock since it IPO’d at the end of April. The company is an impressive player in a big market but the lack of an obvious moat makes the valuation hard to swallow.
TEAM SHOP DBX OKTA DOCU CRM ADBE
Tech has been a big part of the stock market swoon. The sector continued its downward push Wednesday, even after the Trump administration softened its targeting of China and that country's investments in U.S. tech companies.
IBM SHOP UXIN I
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SHOP GOOGL MITL GOOG GIB BBRY CNSWF
Alphabet’s (NASDAQ:GOOGL) division Google is leaving no stone unturned to strengthen presence in the emerging cloud market. The company is set to roll out a new storage option called Cloud Filestore, which will initially be launched at beta stage.
SHOP GOOGL AAPL HUBS
Another week, another bear comes after Shopify Inc (NASDAQ:SHOP). A highly critical report published on Seeking Alpha is making the rounds Wednesday, with SHOP stock down 6% on the session as of this writing.
FB SHOP CRM
Alphabet’s (GOOGL - Free Report) division Google is leaving no stone unturned to strengthen presence in the emerging cloud market. The company is set to roll out a new storage option called Cloud Filestore, which will initially be launched at beta stage. Filestore offers managed file storage services and features network attached storage (“NAS”) facility. This will be of major help to the developers who require filesystem interface and a shared filesystem for data to run their applications.
SHOP GOOGL AAPL HUBS
2017-11-09 - Asif
Shopify provides the leading cloud-based, multi-channel commerce platform designed for small and medium-sized businesses. Merchants use its software to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts, and marketplaces. As the number of channels over which merchants transact continues to expand, the importance of a multi-channel platform that is both fully integrated and easy to use increases. The Shopify platform provides merchants with a single view of their business and customers across all of their sales channels and enables them to manage products and inventory, process orders and payments, ship orders, build customer relationships and leverage analytics and reporting all from one integrated back office. Commerce transacted over mobile devices continues to grow more rapidly than desktop transactions. For several years Shopify has focused on enabling mobile commerce and its merchants ...
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to SHOP / Shopify Inc. on message board site Silicon Investor.
as of ET